Skip to main content
SpringerLink
Log in

The Unique Potential for Noninvasive Imaging in Modernizing Drug Development and in Transforming Therapeutics: PET/MRI/MRS

  • Commentary
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Notes

  1. While in the physical sciences, such as in chemistry, the proper term is nuclear magnetic resonance spectroscopy, NMR for short, the medical sciences have dropped the word "nuclear," and the terms used are MRI for Magnetic Resonance Imaging and MRS for Magnetic Resonance Spectroscopy.

REFERENCES

  1. Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Cherry SR. Simultaneous acquisition of multislice PET and MR Images: initial results with a MR-compatible PET scanner. J Nucl Med. 2006;47:1968–76.

    PubMed  Google Scholar 

  2. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459–65.

    Article  CAS  PubMed  Google Scholar 

  3. Pichler BJ, Kolb A, Nägele T, Schlemmer H-P. PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications. J Nucl Med. 2010;51:333–6.

    Article  PubMed  Google Scholar 

  4. Peremans K, De Spiegeleer B, Buntinx E, Dobbeleir A, Vermeire S, Vandermeulen E, et al. Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain. Nucl Med Commun. 2008;29:724–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hillman BJ, Goldsmith JC. The Uncritical Use of High-Tech Medical Imaging. N Engl J Med. 2010;363:4–6.

    Article  CAS  PubMed  Google Scholar 

  6. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, et al. Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds. Nature. 1957;179:663–6.

    Article  CAS  PubMed  Google Scholar 

  7. Pinedo HM, Peters GF. Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988;6:1653–64.

    CAS  PubMed  Google Scholar 

  8. Rustum YM. Fluoropyrimidines in Cancer Therapy. Totowa: Humana Press; 2003.

    Google Scholar 

  9. Shani J, Wolf W. A Model of Prediction of Chemotherapy Response to 5-FU in Sensitive versus Resistant Lymphocytic Leukemia in Mice. Cancer Res. 1977;37:2306–8.

    CAS  PubMed  Google Scholar 

  10. Young D, Vine E, Ghanbarpour A, Shani J, Siemsen JK, Wolf W. Metabolic and Distribution Studies with Radiolabeled 5-Fluorouracil. Nucl Med. 1982;21:1–7.

    CAS  Google Scholar 

  11. Wolf W, Presant CA, Servis KL, El-Tahtawy A, Albright MJ, Barker PB, et al. Tumor Trapping of 5-Fluorouracil: in vivo 19F -NMR Spectroscopic Pharmacokinetics in Tumor-bearing Humans and rabbits. Proc Natl Acad Sci. 1990;87:492–6.

    Article  CAS  PubMed  Google Scholar 

  12. Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, et al. Association of the Intratumoral Pharmacokinetics of 5-Fluorouracil with Clinical Response: an In-Vivo 19F Nuclear Magnetic Resonance Study. Lancet. 1994;343:1184–7.

    Article  CAS  PubMed  Google Scholar 

  13. Wolf W, Presant CA, Waluch V. Noninvasive Studies of Fluoropyrimidines. In Fluoropyrimidines in Cancer Therapy. In: Youcef Rustum, editor. Cancer Drug Discovery and Development series. Totowa: Humana Press; 2003.

    Google Scholar 

  14. Stevens AN, Morris PG, Iles RA, Sheldon PW, Griffiths JR. 5-Fluorouracil metabolism monitored in vivo by of 5-FU catabolites in human liver. Br J Cancer. 1984;50:113–7.

    Article  CAS  PubMed  Google Scholar 

  15. Wolf W, Presant CA, Waluch V. 19F-MRS Studies of Fluorinated Drugs in Humans. Adv Drug Deliv Rev. 2000;41:5–74.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA

    Walter Wolf

Authors
  1. Walter Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter Wolf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, W. The Unique Potential for Noninvasive Imaging in Modernizing Drug Development and in Transforming Therapeutics: PET/MRI/MRS. Pharm Res 28, 490–493 (2011). https://doi.org/10.1007/s11095-010-0293-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0293-5

Keywords

Search

Navigation